Published date:Apr 17 2018

Journal Title: KnE Energy

Issue title: The 2nd International Symposium "Physics, Engineering and Technologies for Biomedicine"

Pages:420–427

DOI: 10.18502/ken.v3i2.1846

I A Raznitsynaraznitsyna@medphyslab.com

D A Rogatkin

O A Bychenkov

In this paper, possibilities of laser fluorescence spectroscopy to predict the reactions of the oral cavity cancer to radiation treatment are considered. A theoretically substantiated assumption about the link between the tumor’s consumption of an exogenous photosensitizer and its radioresistance is proposed. The first experience with the use of the Radahlorin photosensitizer is described; preliminary results of the 5 patients study are presented. As a result different photosensitizer consumptions versus different treatment outcomes are discussed.

Keywords: laser fluorescence spectroscopy, photosensitizer, oral cavity cancer, radiotherapy, cross-resistance

[1] I. M. Gel’fand, I. S. Romanov, D. B. Udintsov, “Treatment policy for localized oral cancer,” Head and neck tumors, vol.6 (1), pp. 43-45, 2016.


[2] L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet‐Tieulent, & A. Jemal, “Global cancer statistics, 2012,” CA: a cancer journal for clinicians, vol. 65(2), pp. 87-108, 2015.


[3] A I Svirnovskij, V V Pasyukov, “Molekulyarnye osnovy fenomena himio- i radiorezistentnosti pri opuholevyh protsessah”, Meditsinskie novosti, vol. 11, pp. 7-19, 2007. (Russian).


[4] A I Svirnovskij, “Rezistentnost opuholevyh kletok k terapevticheskim vozdejstviyam kak mediko-biologicheskaya problema,” Mezhdunarodnye obzory: Klinicheskaya praktika i zdorove, vol. 5(11), pp. 15-38, 2014. (Russian).


[5] Bryan Q. Spring, Imran Rizvi, Nan Xu and Tayyaba Hasan, “The role of photodynamic therapy in overcoming cancer drug resistance,” Photochem. Photobiol. Sci., vol. 14, pp. 1476-1491, 2015.


[6] I. J. Macdonald, & T. J. Dougherty, “Basic principles of photodynamic therapy,” Journal of Porphyrins and Phthalocyanines, vol. 5(02), pp. 105-129, 2001.


[7] Z. Huang et al, “Photodynamic therapy of cancer—Challenges of multidrug resistance,” Journal of Innovative Optical Health Sciences, vol. 8(1), pp. 1530002, 2015.


[8] E. V. Kochneva, E. V. Filonenko, E. G. Vakulovskaya, E. G. Scherbakova, O. V. Seliverstov, N. A. Markichev, & A. V. Reshetnickov, “Photosensitizer Radachlorin®: Skin cancer PDT phase II clinical trials,” Photodiagnosis and photodynamic therapy, vol. 7(4), pp. 258-267, 2010.


[9] D. Rogatkin, V. Shumskiy, S. Tereshenko, P. Polyakov, “Laser-based non-invasive spectrophotometry–An overview of possible medical applications,” Photonics & Lasers in Medicine, vol. 2(3), pp. 225-240, 2013.


[10] V. V. Tchernyi, D.A. Rogatkin, O.A. Bychenkov, P.Yu. Polyakov, “Some results of multiwave in situ autofluorescence diagnostics,” Proc. SPIE, vol. 5693, pp. 336-343, 2005.


[11] I. Guseva, D. Rogatkin, P. Kulikova, D. Kulikov, “In Vivo experimental detection of inflammatory process in tissues by fluorescence spectroscopy,” Proc. of the 9th Int. Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2016), vol. 1: BIODEVICES, pp.139-144, 2016.


[12] I. M. Fedyaev, I. M. Bajrikov, L. P. Belova, T. V. SHuvalova, “Zlokachestvennye opukholi chelyustno-litsevoj oblasti,” M: Meditsinskaya kniga, N.Novgorod: Izd-vo NGMD, 2000. 160 pp. (Russian).